164 related articles for article (PubMed ID: 20646839)
1. Accuracy of proton beam range verification using post-treatment positron emission tomography/computed tomography as function of treatment site.
Knopf AC; Parodi K; Paganetti H; Bortfeld T; Daartz J; Engelsman M; Liebsch N; Shih H
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):297-304. PubMed ID: 20646839
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scans.
Knopf A; Parodi K; Bortfeld T; Shih HA; Paganetti H
Phys Med Biol; 2009 Jul; 54(14):4477-95. PubMed ID: 19556685
[TBL] [Abstract][Full Text] [Related]
3. Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy.
Parodi K; Paganetti H; Shih HA; Michaud S; Loeffler JS; DeLaney TF; Liebsch NJ; Munzenrider JE; Fischman AJ; Knopf A; Bortfeld T
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):920-34. PubMed ID: 17544003
[TBL] [Abstract][Full Text] [Related]
4. In vivo verification of proton beam path by using post-treatment PET/CT imaging.
Hsi WC; Indelicato DJ; Vargas C; Duvvuri S; Li Z; Palta J
Med Phys; 2009 Sep; 36(9):4136-46. PubMed ID: 19810487
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy.
Moteabbed M; España S; Paganetti H
Phys Med Biol; 2011 Feb; 56(4):1063-82. PubMed ID: 21263174
[TBL] [Abstract][Full Text] [Related]
6. PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.
Parodi K; Paganetti H; Cascio E; Flanz JB; Bonab AA; Alpert NM; Lohmann K; Bortfeld T
Med Phys; 2007 Feb; 34(2):419-35. PubMed ID: 17388158
[TBL] [Abstract][Full Text] [Related]
7. Automation and uncertainty analysis of a method for in-vivo range verification in particle therapy.
Frey K; Unholtz D; Bauer J; Debus J; Min CH; Bortfeld T; Paganetti H; Parodi K
Phys Med Biol; 2014 Oct; 59(19):5903-19. PubMed ID: 25211629
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of post treatment positron emission tomography/computed tomography to detect inter-fractional range variations in scanned ion beam therapy.
Handrack J; Tessonnier T; Chen W; Liebl J; Debus J; Bauer J; Parodi K
Acta Oncol; 2017 Nov; 56(11):1451-1458. PubMed ID: 28918686
[TBL] [Abstract][Full Text] [Related]
9. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
[TBL] [Abstract][Full Text] [Related]
10. Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code.
Parodi K; Ferrari A; Sommerer F; Paganetti H
Phys Med Biol; 2007 Jun; 52(12):3369-87. PubMed ID: 17664549
[TBL] [Abstract][Full Text] [Related]
11. The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributions.
España S; Paganetti H
Phys Med Biol; 2010 Dec; 55(24):7557-71. PubMed ID: 21098912
[TBL] [Abstract][Full Text] [Related]
12. A filtering approach based on Gaussian-powerlaw convolutions for local PET verification of proton radiotherapy.
Parodi K; Bortfeld T
Phys Med Biol; 2006 Apr; 51(8):1991-2009. PubMed ID: 16585841
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
14. The development and clinical use of a beam ON-LINE PET system mounted on a rotating gantry port in proton therapy.
Nishio T; Miyatake A; Ogino T; Nakagawa K; Saijo N; Esumi H
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):277-86. PubMed ID: 20005459
[TBL] [Abstract][Full Text] [Related]
15. Physiologic reactions after proton beam therapy in patients with prostate cancer: significance of urinary autoactivation.
Shimizu M; Sasaki R; Miyawaki D; Nishimura H; Demizu Y; Akagi T; Suga D; Sakamoto H; Murakami M; Sugimura K; Hishikawa Y
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):580-6. PubMed ID: 19735884
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.
Schmid S; Landry G; Thieke C; Verhaegen F; Ganswindt U; Belka C; Parodi K; Dedes G
Phys Med Biol; 2015 Dec; 60(24):9329-47. PubMed ID: 26581022
[TBL] [Abstract][Full Text] [Related]
17. An experimental approach to improve the Monte Carlo modelling of offline PET/CT-imaging of positron emitters induced by scanned proton beams.
Bauer J; Unholtz D; Kurz C; Parodi K
Phys Med Biol; 2013 Aug; 58(15):5193-213. PubMed ID: 23835872
[TBL] [Abstract][Full Text] [Related]
18. Extension and validation of an analytical model for in vivo PET verification of proton therapy--a phantom and clinical study.
Attanasi F; Knopf A; Parodi K; Paganetti H; Bortfeld T; Rosso V; Del Guerra A
Phys Med Biol; 2011 Aug; 56(16):5079-98. PubMed ID: 21775794
[TBL] [Abstract][Full Text] [Related]
19. Accounting for prompt gamma emission and detection for range verification in proton therapy treatment planning.
Tian L; Huang Z; Janssens G; Landry G; Dedes G; Kamp F; Belka C; Pinto M; Parodi K
Phys Med Biol; 2021 Feb; 66(5):055005. PubMed ID: 33171445
[TBL] [Abstract][Full Text] [Related]
20. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes.
Mohan R; Zhang X; Wang H; Kang Y; Wang X; Liu H; Ang KK; Kuban D; Dong L
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1258-66. PubMed ID: 15752908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
